LWBJ congratulates Eurofins on top ranking for value creation
WEST DES MOINES, January 22, 2018 – Coinciding with the 20th anniversary of its initial public offering, Eurofins has been ranked first in value creation among all stocks listed in Europe since October 24, 1997. According to data from Marten & Co., a U.K. independent research firm, total returns for Eurofins shareholders advanced at a 33 percent compound annual growth rate (CAGR) from October 1997 to October 2017.
In addition, the company outperformed key benchmark indices (CAC 40, SBF 120 and S&P 500) by an average of more than 29 percent CAGR during the 20-year period. View the press release at
LWBJ has provided due diligence and financial advisory services to Eurofins Scientific SE on more than 20 acquisitions in the United States and Canada.
We recently assisted the company in its acquisition of EAG Laboratories, a portfolio company of Odyssey Investment Partners. The transaction was valued at $780 million on a cash-free, debt-free basis and closed on December 1, 2017. View the press release at
In congratulating Eurofins, LWBJ Managing Partner Paul Juffer noted, “We are honored to have the opportunity to help Eurofins pursue its strategic growth initiatives, and we look forward to the company’s continued success in the years ahead.”
Eurofins Scientific SE is a world leader in food, environment, and pharmaceuticals products testing and one of the global independent market leaders in testing and laboratory services for agroscience, genomics, and discovery pharmacology, as well as for supporting clinical studies. Eurofins is also a key emerging player in specialty clinical diagnostic testing in Europe and the United States. The company has more than 30,000 employees in 375 laboratories across 41 countries and is listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).